PWM
CRVO icon

Perigon Wealth Management’s CervoMed CRVO Stock Holding History

Perigon Wealth Management’s Portfolio CRVO Stock Details CRVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-29,531
Closed -$233K – 1318
2025
Q4 		$233K Buy
29,531
+800
+3% +$6.43K ﹤0.01% 1148
2025
Q3 		$232K Buy
28,731
+11,425
+66% +$98K ﹤0.01% 1074
2025
Q2 		$109K Sell
17,306
-900
-5% -$7.67K ﹤0.01% 1032
2025
Q1 		$167K Sell
18,206
-44,523
-71% -$170K ﹤0.01% 982
2024
Q4 		$132K Buy
+62,729
New +$610K ﹤0.01% 1014

Other funds holding CRVO

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
CFG
Citizens Financial Group Providence, Rhode Island $8.3B AUM 27.66% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Perigon Wealth Management's CRVO Position: Q1 2026 in Review

Perigon Wealth Management sold out of CervoMed (CRVO) in Q1 2026, closing a stake of 29,531 shares — an estimated $233K sold.

Perigon Wealth Management first reported a position in CRVO in Q4 2024 and held it in 5 quarters. The position peaked at $233K in Q4 2025. 36 funds tracked by Wall St. Rank hold CRVO as of Q1 2026.

  • Perigon Wealth Management reported no remaining CervoMed position as of Q1 2026 after selling out during the quarter.
  • Perigon Wealth Management sold 29,531 CervoMed shares in Q1 2026, an estimated $233K.
  • Perigon Wealth Management first reported a position in CervoMed in Q4 2024 and held it in 5 quarters.
  • Perigon Wealth Management's CervoMed position peaked at $233K in Q4 2025.
  • 36 funds tracked by Wall St. Rank held CervoMed as of Q1 2026.

Based on Perigon Wealth Management's 13F filing for Q1 2026, filed 10 Apr 2026.